SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling.

Détails

Ressource 1Télécharger: 36238311_BIB_F15ADD1BCF3A.pdf (11223.18 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_F15ADD1BCF3A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling.
Périodique
Frontiers in immunology
Auteur⸱e⸱s
Jha A., Ahad A., Mishra G.P., Sen K., Smita S., Minz A.P., Biswas V.K., Tripathy A., Senapati S., Gupta B., Acha-Orbea H., Raghav S.K.
ISSN
1664-3224 (Electronic)
ISSN-L
1664-3224
Statut éditorial
Publié
Date de publication
2022
Peer-reviewed
Oui
Volume
13
Pages
910705
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Dendritic cell (DC) fine-tunes inflammatory versus tolerogenic responses to protect from immune-pathology. However, the role of co-regulators in maintaining this balance is unexplored. NCoR1-mediated repression of DC immune-tolerance has been recently reported. Here we found that depletion of NCoR1 paralog SMRT (NCoR2) enhanced cDC1 activation and expression of IL-6, IL-12 and IL-23 while concomitantly decreasing IL-10 expression/secretion. Consequently, co-cultured CD4 <sup>+</sup> and CD8 <sup>+</sup> T-cells depicted enhanced Th1/Th17 frequency and cytotoxicity, respectively. Comparative genomic and transcriptomic analysis demonstrated differential regulation of IL-10 by SMRT and NCoR1. SMRT depletion represses mTOR-STAT3-IL10 signaling in cDC1 by down-regulating NR4A1. Besides, Nfkbia and Socs3 were down-regulated in Ncor2 (Smrt) depleted cDC1, supporting increased production of inflammatory cytokines. Moreover, studies in mice showed, adoptive transfer of SMRT depleted cDC1 in OVA-DTH induced footpad inflammation led to increased Th1/Th17 and reduced tumor burden after B16 melanoma injection by enhancing oncolytic CD8 <sup>+</sup> T-cell frequency, respectively. We also depicted decreased Ncor2 expression in Rheumatoid Arthritis, a Th1/Th17 disease.
Mots-clé
Animals, CD8-Positive T-Lymphocytes/metabolism, Cytokines/metabolism, Dendritic Cells/metabolism, Interleukin-10/metabolism, Interleukin-12/metabolism, Interleukin-23/metabolism, Interleukin-6/metabolism, Mice, Nuclear Receptor Co-Repressor 1/genetics, Nuclear Receptor Co-Repressor 1/metabolism, Nuclear Receptor Co-Repressor 2, STAT3 Transcription Factor, TOR Serine-Threonine Kinases/metabolism, Nr4a1, SMRT and NCoR1, Th1/Th17 T-cell response, comparative genomic and transcriptomic (RNA-seq and ChIP-seq), dendritic cells, mTOR-STAT3-IL10 signaling
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/10/2022 12:27
Dernière modification de la notice
08/08/2024 6:42
Données d'usage